The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Induction chemotherapy with cisplatin, 5-fluorouracil, and cetuximab followed by radiotherapy and cetuximad in head and neck cancers: Preliminary results of a modern integrated approach.
R. M. D'Angelillo
No relevant relationships to disclose
L. Trodella
No relevant relationships to disclose
F. Cellini
No relevant relationships to disclose
M. Fiore
No relevant relationships to disclose
C. Greco
No relevant relationships to disclose
B. Floreno
No relevant relationships to disclose
L. E. Trodella
No relevant relationships to disclose
A. Iurato
No relevant relationships to disclose
E. Ippolito
No relevant relationships to disclose
S. Ramella
No relevant relationships to disclose